Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8296-8302

  Cecil, Denise L ^a   Johnson, Kristen ^a   Rediske, John ^c   Lotz, Martin ^d   Schmidt, Ann Marie ^b   Terkeltaub, Robert ^a,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Columbia University ^*  (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; COLLAGEN TYPE 10; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; POLYPEPTIDE; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NERVE DEGENERATION; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR DISEASE;

EID: 29144510038     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8296     Document Type: Article

References (43)

1. Goldring, M. B. 2000. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43: 1916-1926.
2. Pelletier, J. P., J. Martel-Pelletier, and S. B. Abramson. 2001. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 44: 1237-1247.
3. Pulai, J. L, H. Chen, H. J. Im, S. Kumar, C. Hanning, P. S. Hegde, and R. F. Loeser. 2005. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J. Immunol. 174: 5781-5788.
4. Kobayashi, M., G. R. Squires, A. Mousa, M. Tanzer, D. J. Zukor, J. Antoniou, U. Feige, and A. R. Poole. 2005. Role of interleukin-1 and tumor necrosis factor α in matrix degradation of human osteoatthritic cartilage. Arthritis Rheum. 52: 128-135.
5. Recklies, A. D., and E. E. Golds. 1992. Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum. 35: 1510-1519.
6. Borzi, R. M., I. Mazzetti, S. Macor, T. Silvestri, A. Bassi, L. Cattini, and A, Facchini. 1999. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 455: 238-242.
7. Facchini, A., R. M. Borzi, K. B. Marcu, C. Stefanelli, E. Olivotto, M. B. Goldring, A. Facchini, and F. Flamigni. 2005. Polyamine depletion inhibits NF-κB binding to DNA and interleukin-8 production in human chondrocytes stimulated by tumor necrosis factor-α. J. Cell. Physiol. 204: 956-963.
8. Merz, D., R. Liu, K. Johnson, and R. A. Terkeltaub. 2003. IL-8/CXCL8 and growth-related oncogene α/CXCL1 induce chondrocyte hypertrophic differentiation. J. Immunol. 171: 4406-4415.
9. Johnson, K, A., D. van Etten, N. Nanda, R. M. Graham, and R. A. Terkeltaub. 2003. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J. Biol. Chem. 278: 18824-18832.
10. Kirsch, T., B. Swoboda, and H. Nah. 2000. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 8: 294-302.
11. Ramasamy, R., S. J. Vannucci, S. Shi Du Yan, K. Herold, S. Fang Yan, and A. Marie Schmidt. 2005. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15: 16R-28R.
12. Cooper, M. E. 2004. Importance of advanced glycation end products in diabetesassociated cardiovascular and renal disease. Am. J. Hypertens. 17: 31S-38S.
13. Chavakis, T., A. Bierhaus, and P. P. Nawroth. 2004. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 6: 1219-1225.
14. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
15. Ravasi, T., K. Hsu, J. Goyette, K. Schroder, Z. Yang, F. Rahimi, L. P. Miranda, P. F. Alewood, D. A. Hume, and C. Geczy. 2004. Probing the S100 protein family through genomic and functional analysis. Genomics 84: 10-22.
16. Marenholz, I., C. W. Heizmann, and G. Fritz. 2004. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322: 1111-1122.
17. Balmain, N., F. Moutahir, C. W. Heizmann, and M. Lieberherr. 2003. Immunolocalization of S100A2 calcium-binding protein in cartilage and bone cells. Cell. Mal. Biol. (Noisy-le-grand) 49: 485-486.
18. Loeser, R. F., R. R. Yammani, C. S. Carlson, H. Chen, A. Cole, H. J. Im, L. S. Bursch, and S. D. Yan. 2005. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 52: 2376-2385.
19. Zimmer, D. B., E. H. Cornwall, A. Landar, and W. Song. 1995. The S100 protein family: history, function, and expression. Brain Res. Bull. 37: 417-429.
20. Gonzalez-Campora, R., C. Otal Salaverri, A. Gomez Pascual, A. Hevia Vazquez, and H. Galera Davidson. 1995. Mesenchymal chondrosarcoma of the retroperitoneum: report of a case diagnosed by fine needle aspiration biopsy with immunohistochemical, electron microscopic demonstration of S-100 protein in undifferentiated cells. Acta Cytol. 39: 1237-1243.
21. Foell, D., M. Frosch, C. Sorg, and J. Roth. 2004. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta 344: 37-51.
22. Foell, D., and J. Roth. 2004. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50: 3762-3771.
23. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98: 1088-1094.
24. Arumugam, T., D. M. Simeone, A. M. Schmidt, and C. D. Logsdon. 2004. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 279: 5059-5065.
25. Han, Q., J. Leng, D. Bian, C. Mahanivong, K. A. Carpenter, Z. K. Pan, J. Han, and S. Huang. 2002. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J. Biol. Chem. 277: 48379-48385.
26. Cecil, D. L., D. M. Rose, R. A. Terkeltaub, and R. Liu-Bryan. 2005. Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes. Arthritis Rheum. 52: 144-154.
27. Robinson, N. A., and R. L. Eckert. 1998. Identification of transglutaminase-reactive residues in S100A11. J. Biol. Chem. 273: 2721-2728.
28. Moroz, O. V., A. A. Antson, E. J. Dodson, H. J. Burrell, S. J. Grist, R. M. Lloyd, N. J. Maitland, G. G. Dodson, K. S. Wilson, E. Lukanidin, and I. B. Bronstein. 2002. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. D Biol. Crystallogr. 58: 407-413.
29. Robinson, M. J., P. Tessier, R. Poulsom, and N. Hogg. 2002. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells, J. Biol. Chem. 277: 3658-3665.
30. Kerkhoff, C., C. Sorg, N. N. Tandon, and W. Nacken. 2001. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 40: 241-248.
31. Sakaguchi, M., M. Miyazaki, H, Sonegawa, M. Kashiwagi, M, Ohba, T. Kuroki, M. Namba, and N. H. Huh. 2004. PKCα mediates TGFβ-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J. Cell Biol. 164: 979-984.
32. Robinson, M. J., P. Tessier, R. Poulsom, and N. Hogg. 2002. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277: 3658-3665.
33. DeGroot, J., N. Verzijl, K. M. Jacobs, M. Budde, R. A. Bank, J. W. Bijlsma, J. M. TeKoppele, and F, P. Lafeber. 2001. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 9: 720-726.
34. Kokkola, R., A, Andersson, G. Mullins, T. Ostberg, C. J. Treutiger, B. Arnold, P. Nawroth, U. Andersson, R. A. Harris, and H. E. Harris. 2005. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol 61: 1-9.
35. Kokkola, R., J. Li, E. Sundberg, A. C. Aveberger, K. Palmblad, H. Yang, K. J. Tracey, U. Andersson, and H. E. Harris. 2003. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48: 2052-2058.
36. Taniguchi, N., K. Kawahara, K. Yone, T. Hashiguchi, M. Yamakuchi, M. Goto, K. Inoue, S. Yamada, K. Ijiri, S. Matsunaga, et al. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48: 971-981.
37. Sakaguchi, M., M. Miyazaki, T. Kondo, and M. Namba. 2001. Up-regulation of S100C in normal human fibroblasts in the process of aging in vitro. Exp. Gerontol 36: 1317-1325.
38. Makino, E., M. Sakaguchi, K. Iwatsuki, and N. H. Huh. 2004. Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J. Mol. Med. 82: 612-620.
39. Hudson, B. I., E. Harja, B. Moser, and A. M. Schmidt. 2005. Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? Arterioscler. Thromb. Vasc. Biol. 25: 879-882.
40. Hanford, L. E., J. J. Enghild, Z. Valnickova, S. V. Petersen, L. M. Schaefer, T. M. Schaefer, T. A. Reinhart, and T. D. Oury. 2004. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 279: 50019-50024.
41. Ruse, M., A. Lambert, N. Robinson, D. Ryan, K. J. Shon, and R. L. Eckert. 2001. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 40: 3167-3173.
42. Robinson, N. A., and R. L. Eckert. 1998. Identification of transglutaminase-reactive residues in S100A11. J. Biol. Chem. 273: 2721-2728.
43. Johnson, K. A., and R. A. Terkeltaub. 2005. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J. Biol. Chem. 280: 15004-15012.